Form 4: H.B. Fuller President and CEO, Celeste Beeks Mastin, Reports Stock Option Grant and Restricted Stock Unit Awards
SEC Form 4 Filing
Celeste Beeks Mastin, President and CEO of H.B. Fuller, reports the acquisition of stock options and restricted stock units, along with adjustments to her holdings.
Summary
- Celeste Beeks Mastin, President and CEO of H.B. Fuller, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- On January 27, 2025, Mastin acquired 135,135 employee stock options with an exercise price of $64.28, vesting in three annual installments starting January 27, 2026, and expiring on January 27, 2035.
- She also acquired 23,666 restricted stock units (RSUs) that convert into common stock on a 1-for-1 basis, vesting in three annual installments starting January 27, 2026, and ending January 27, 2028.
- The report also details existing holdings of employee stock options with various exercise prices and vesting schedules, as well as restricted stock units.
- Mastin directly owns 11,988 shares of H.B. Fuller common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of stock options and RSUs could be interpreted as a positive sign of management's confidence, but it's a standard practice.
Positives
- The acquisition of stock options and restricted stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value.
Comparison to Industry Standards
- Stock option and RSU grants are common compensation practices among publicly traded companies, including competitors like Avery Dennison and 3M.
- The vesting schedules and exercise prices are generally in line with industry standards for executive compensation packages.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
- Employees may be impacted by the overall compensation structure and incentives for management.
Key Dates
| Date | Description |
|---|---|
| 04/07/2023 | Date of employee stock option grant with an exercise price of $67.55. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17 and restricted stock unit grant. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72 and restricted stock unit grant. |
| 01/27/2025 | Date of transaction for new stock options and restricted stock units. |
| 01/27/2026 | First vesting date for new stock options and restricted stock units. |
| 01/27/2028 | Final vesting date for the new restricted stock units. |
| 01/24/2033 | Expiration date for employee stock option grant with an exercise price of $68.17. |
| 01/26/2034 | Expiration date for employee stock option grant with an exercise price of $77.72. |
| 01/27/2035 | Expiration date for new stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.